Analysis of information asymmetry in the instructions for medical use on the example of Enterol
Abstract
There may be variations in the texts of instructions for medical use of medicines (hereinafter – the instructions) containing the same active pharmaceutical ingredient, and registered in the pharmaceutical markets of different countries. First of all this applies to medicines manufactured in one country and distributed to other countries. Therefore, there are questions related to incorrect use of medicines due to the existing asymmetry of information. This problem is especially relevant in connection with tourist activity and labour migration.
The aim of the study was to identify discrepancies in the instructions of Enterol, registered in different countries.
The materials of the study were the registers of medicines in France, Ukraine, Belarus, Bulgaria, Poland, the Czech Republic and Russia, as well as the texts of instructions of Enterol (Biocodex, France), registered in the above countries. Methods of generalization, systematization, as well as contextual and comparative analysis were used.
It was found that the original (French) instruction has two indications for the use of Enterol (treatment of acute diarrhea in children under 12 years old; prevention of antibiotic-associated diarrhea caused by Clostridium difficile or recurrence of diarrhea caused by Clostridium difficile), while Belarusian and Russian instructions have one indication. Polish instruction contains 5 indications, while Bulgarian and Czech – 8. The largest number of indications for the use of Enterol (11) is given in Ukrainian instruction.
A contradictory information is in the sections «Therapeutic Indications», «Posology and method of administration», «Contraindications», «Undesirable effects», «Special warnings and precautions for use», including «Pregnancy and lactation». In the text of one instruction there is no information available in the text of another, and none of the instructions is identical to the instructions of Enterol, registered in France (country of manufacture). Actually, these information discrepancies, as well as the patient's perception of information, can lead to improper use of medicines and, as a consequence, drug-related problems. Thus, to minimize the asymmetry of information, the applicant during the registration of the drug must submit a notarized translation of the manufacturer's instructions.
References
Probiotics market size, share & trends analysis report by product (food & beverages, dietary supplements), by ingredient (bacteria, yeast), by end use, by distribution channel, and segment forecasts, 2019–2025. – Available from: https://www.grandviewresearch.com/industry-analysis/probiotics-market/
Guarner F., Sanders M. E., Eliakim R. et al. World Gastroenterology organization. Probiotics and prebiotics. – Available from: https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english/
McFarland L. V., Evans C. T., Goldstein E. J. C. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis // Front Med (Lausanne). – 2018. – N 7. https://doi.org/10.3389/fmed.2018.00124
Storr M., Stengel A. Klinische evidenz zu probiotika in der prävention einer antibiotika-assoziierten diarrhö : systematischer review // MMW Fortschr. – 2021. – N 163. – P. 19–26. https://doi.org/10.1007/s15006-021-9762
Chukhray I., Bilushchak H., Kolyasa L. et al. Expert evaluation of consumer properties of probiotics marketed in Ukraine // Current Issues in Pharmacy and Medical Sciences. – 2018. – N 31. – P. 76–80. https://doi.org/10.1515/cipms-2018-0015
Derzhavnyi reiestr likarskykh zasobiv. – Rezhym dostupu: http://www.drlz.com.ua/
National registers of authorised medicines. – Available from: https://www.ema.europa.eu/en/medicines/national-registers-authorised-medicines
Hosudarstvennyi reestr lekarstvennykh sredstv. – Rezhym dostupa: https://grls.rosminzdrav.ru/GRLS.aspx?RegNumber=&MnnR=&lf=&TradeNmR=%Энтерол%
Reestr lekarstvennykh sredstv Respublyky Belarus. – Rezhym dostupa: http://www.rceth.by/Refbank/
Nakaz MOZ Ukrainy vid 26. 08. 2005 r. № 426 «Рro zatverdzhennia poriadku provedennia ekspertyzy reiestratsiinykh materialiv na likarski zasoby shcho podaiutsia na derzhavnu reiestratsiiu (perereiestratsiiu) a takozh ekspertyzy materialiv pro vnesennia zmin do reiestratsiinykh materialiv protiahom dii reiestratsiinoho posvidchennia». – Rezhym dostupu: http://zakon2.rada.gov.ua/laws/show/z1069–05
Hadiak I. V., Hromovyk B. P. Doslidzhennia zmistu ofitsiino zatverdzhenoi informatsii pro medychne zastosuvannia torhovykh marok tamsulozynu // Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. – 2018. – № 1. – S. 20–27. https://doi.org/10.24959/uekj.18.2
Hromovyk B. P., Matviichuk M. Ye. Doslidzhennia asymetrii informatsii normatyvnykh dokumentiv shchodo likarskykh zasobiv dlia farmakoterapii depresyvnykh rozladiv u vahitnykh i porodil // Farmats. chasopys. – 2019. – № 3. – S. 111–122. https://doi.org/10.11603/2312-0967.2019.3.10408/
Unhurian L. M., Bieliaieva О. І., Smirnova О. В. ta in. Porivnialnyi analiz spozhyvchykh vlastyvostei valsartanvmisnykh preparativ Z pohliadu asymetrii informatsii // Farmats. сhasopys. – № 3. – S. 53-59. https://doi.org/10.11603/2312-0967.2020.3.11426
This work is licensed under a Creative Commons Attribution 4.0 International License.
